Nutex Health (NASDAQ:NUTX) Announces Quarterly Earnings Results

Nutex Health (NASDAQ:NUTX) released its earnings results on Thursday. The company reported $1.61 earnings per share for the quarter, missing analysts’ consensus estimates of $5.56 by ($3.95), Zacks reports. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The business had revenue of $151.68 million during the quarter, compared to analysts’ expectations of $258.82 million.

Nutex Health Price Performance

Shares of Nutex Health stock traded down $11.35 on Friday, hitting $93.99. The company’s stock had a trading volume of 393,456 shares, compared to its average volume of 198,218. The company has a market capitalization of $664.51 million, a price-to-earnings ratio of 5.08 and a beta of 0.03. Nutex Health has a 1 year low of $40.67 and a 1 year high of $193.07. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.18 and a current ratio of 3.20. The firm has a fifty day moving average price of $138.40 and a 200-day moving average price of $124.53.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Nutex Health in a research report on Monday, December 29th. Wall Street Zen raised Nutex Health from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 28th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $252.50.

Institutional Investors Weigh In On Nutex Health

A number of institutional investors have recently added to or reduced their stakes in NUTX. Topline Capital Management LLC increased its holdings in Nutex Health by 72.0% in the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock worth $38,484,000 after acquiring an additional 129,418 shares in the last quarter. Millennium Management LLC grew its position in shares of Nutex Health by 191.1% in the third quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after purchasing an additional 61,308 shares during the period. Pertento Partners LLP increased its stake in shares of Nutex Health by 20.0% during the fourth quarter. Pertento Partners LLP now owns 324,422 shares of the company’s stock worth $53,406,000 after purchasing an additional 54,001 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Nutex Health by 12.7% during the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock worth $22,209,000 after purchasing an additional 24,275 shares during the last quarter. Finally, UBS Group AG lifted its stake in Nutex Health by 51.3% in the 3rd quarter. UBS Group AG now owns 68,791 shares of the company’s stock valued at $7,107,000 after buying an additional 23,316 shares in the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.